Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T92609 | Target Info | |||
Target Name | Adrenergic receptor alpha-1A (ADRA1A) | ||||
Synonyms |
Alpha-adrenergic receptor 1c; Alpha-1C adrenergic receptor; Alpha-1A adrenoreceptor; Alpha-1A adrenoceptor; Alpha-1A adrenergic receptor; Alpha adrenergic receptor 1c; Alpha 1A-adrenoreceptor; Alpha 1A-adrenoceptor; ADRA1C
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | ADRA1A | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Adrenergic receptor alpha-1D (ADRA1D) | Successful Target | ||||
UniProt ID | ADA1D_HUMAN | |||||
Gene Name | ADRA1D | |||||
Synonyms |
Alpha-adrenergic receptor 1a; Alpha-1D adrenoreceptor; Alpha-1D adrenoceptor; Alpha-1D adrenergic receptor; Alpha adrenergic receptor 1a; Alpha 1D-adrenoreceptor; Alpha 1D-adrenoceptor; ADRA1A
Click to Show/Hide
|
|||||
Representative Drug(s) | Tamsulosin | Drug Info | Ki = 0.058 nM | Click to Show More | [1] | |
2 | NAFTOPIDIL | Drug Info | Ki = 1.202 nM | [4] | ||
3 | SILODOSIN | Drug Info | Ki = 1.995 nM | [5] | ||
Co-Target Name | Adrenergic receptor alpha-1B (ADRA1B) | Successful Target | ||||
UniProt ID | ADA1B_HUMAN | |||||
Gene Name | ADRA1B | |||||
Synonyms |
Alpha-1B adrenoreceptor; Alpha-1B adrenoceptor; Alpha-1B adrenergic receptor; Alpha 1B-adrenoreceptor; Alpha 1B-adrenoceptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Tamsulosin | Drug Info | EC50 = 0.13 nM | Click to Show More | [2] | |
2 | SILODOSIN | Drug Info | Ki = 19.95 nM | [5] | ||
3 | NAFTOPIDIL | Drug Info | Ki = 19.95 nM | [4] | ||
Co-Target Name | Dopamine D3 receptor (D3R) | Successful Target | ||||
UniProt ID | DRD3_HUMAN | |||||
Gene Name | DRD3 | |||||
Synonyms |
D(3) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Tamsulosin | Drug Info | Ki = 0.28 nM | [3] | ||
Co-Target Name | 5-HT 1A receptor (HTR1A) | Successful Target | ||||
UniProt ID | 5HT1A_HUMAN | |||||
Gene Name | HTR1A | |||||
Synonyms |
Serotonin receptor 1A; G-21; ADRBRL1; ADRB2RL1; 5-hydroxytryptamine receptor 1A; 5-HT1A receptor; 5-HT1A; 5-HT-1A
Click to Show/Hide
|
|||||
Representative Drug(s) | Tamsulosin | Drug Info | Ki = 0.79 nM | [3] | ||
Co-Target Name | Adrenergic receptor Alpha-2 (ADRA2) | Successful Target | ||||
UniProt ID | ADA2A_HUMAN; ADA2B_HUMAN; ADA2C_HUMAN | |||||
Gene Name | NO-GeName | |||||
Synonyms |
Alpha-2 adrenergic receptor; Alpha(2)-adrenoceptor
Click to Show/Hide
|
|||||
Representative Drug(s) | MEDETOMIDINE | Drug Info | EC50 = 3 nM | Click to Show More | [6] | |
2 | MEDETOMIDINE | Drug Info | EC50 = 3 nM | [6] | ||
Co-Target Name | Adrenergic receptor alpha-2C (ADRA2C) | Successful Target | ||||
UniProt ID | ADA2C_HUMAN | |||||
Gene Name | ADRA2C | |||||
Synonyms |
Subtype C4; Alpha-2CAR; Alpha-2C adrenoreceptor; Alpha-2C adrenoceptor; Alpha-2C adrenergic receptor; Alpha-2 adrenergic receptor subtype C4; ADRA2RL2; ADRA2L2
Click to Show/Hide
|
|||||
Representative Drug(s) | Tamsulosin | Drug Info | Ki = 7.9 nM | [1] | ||
Co-Target Name | Dopamine D2 receptor (D2R) | Successful Target | ||||
UniProt ID | DRD2_HUMAN | |||||
Gene Name | DRD2 | |||||
Synonyms |
Dopamine receptor 2; D(2) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Tamsulosin | Drug Info | Ki = 13 nM | [3] | ||
Co-Target Name | Adrenergic receptor alpha-2A (ADRA2A) | Successful Target | ||||
UniProt ID | ADA2A_HUMAN | |||||
Gene Name | ADRA2A | |||||
Synonyms |
Alpha-2AAR; Alpha-2A adrenoreceptor; Alpha-2A adrenoceptor; Alpha-2A adrenergic receptor; Alpha-2 adrenergic receptor subtype C10; ADRAR; ADRA2R
Click to Show/Hide
|
|||||
Representative Drug(s) | Tamsulosin | Drug Info | Ki = 13.4 nM | [1] | ||
Co-Target Name | Norepinephrine transporter (NET) | Successful Target | ||||
UniProt ID | SC6A2_HUMAN | |||||
Gene Name | SLC6A2 | |||||
Synonyms |
Solute carrier family 6 member 2; Sodium-dependent noradrenaline transporter; SLC6A2; NET1; NET; NAT1
Click to Show/Hide
|
|||||
Representative Drug(s) | Besipirdine | Drug Info | IC50 = 430 nM | [7] | ||
Co-Target Name | 5-HT 7 receptor (HTR7) | Clinical trial Target | ||||
UniProt ID | 5HT7R_HUMAN | |||||
Gene Name | HTR7 | |||||
Synonyms |
Serotonin receptor 7; 5HT7; 5-hydroxytryptamine receptor 7; 5-HT7 receptor; 5-HT7; 5-HT-X; 5-HT-7
Click to Show/Hide
|
|||||
Representative Drug(s) | Tamsulosin | Drug Info | Ki = 84 nM | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist for the symptomatic treatment of benign prostatic hyperplasia. J Med Chem. 1997 Sep 26;40(20):3141-3. | ||||
REF 2 | Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as alpha. Bioorg Med Chem. 2016 Nov 1;24(21):5582-91. | ||||
REF 3 | Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists. J Med Chem. 2000 Jun 1;43(11):2183-95. | ||||
REF 4 | Novel naftopidil derivatives containing methyl phenylacetate and their blocking effects on alpha. Bioorg Med Chem Lett. 2018 Feb 15;28(4):547-51. | ||||
REF 5 | Pharmacological options in the treatment of benign prostatic hyperplasia. J Med Chem. 1997 Apr 25;40(9):1293-315. | ||||
REF 6 | A structure-activity relationship study of benzylic modifications of 4-[1-(1-naphthyl)ethyl]-1H-imidazoles on alpha 1- and alpha 2-adrenergic recep... J Med Chem. 1994 Jul 22;37(15):2328-33. | ||||
REF 7 | Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeu... J Med Chem. 1996 Jan 19;39(2):570-81. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.